Ameritas Investment Partners’s X4 Pharmaceuticals XFOR Stock Holding History

Ameritas Investment Partners’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-339	Closed	-$2.4K	–	3359
2025 Q1	$2.4K	Hold	339	–	–	﹤0.01%	3065
2024 Q4	$7.46K	Hold	339	–	–	﹤0.01%	2973
2024 Q3	$6.8K	Hold	339	–	–	﹤0.01%	2998
2024 Q2	$5.9K	Hold	339	–	–	﹤0.01%	3022
2024 Q1	$14.1K	Hold	339	–	–	﹤0.01%	2703
2023 Q4	$8.53K	Hold	339	–	–	﹤0.01%	2884
2023 Q3	$11.1K	Hold	339	–	–	﹤0.01%	2801
2023 Q2	$19.7K	Buy	+339	New	+$17.4K	﹤0.01%	2572
2021 Q2	–	Sell	-33	Closed	-$8K	–	3247
2021 Q1	$8K	Hold	33	–	–	﹤0.01%	2930
2020 Q4	$6K	Hold	33	–	–	﹤0.01%	2947
2020 Q3	$7K	Hold	33	–	–	﹤0.01%	2890
2020 Q2	$9K	Hold	33	–	–	﹤0.01%	2783
2020 Q1	$10K	Hold	33	–	–	﹤0.01%	2565
2019 Q4	$11K	Hold	33	–	–	﹤0.01%	2707
2019 Q3	$13K	Buy	33 +31	+1,550%	+$12.3K	﹤0.01%	2625
2019 Q2	$1K	Hold	2	–	–	﹤0.01%	3039
2019 Q1	$1K	Hold	2	–	–	﹤0.01%	2968
2018 Q4	$1K	Hold	2	–	–	﹤0.01%	2982
2018 Q3	$1K	Hold	2	–	–	﹤0.01%	3015
2018 Q2	$1K	Hold	2	–	–	﹤0.01%	2998
2018 Q1	$9K	Buy	+2	New	+$5.82K	﹤0.01%	2764

Other funds holding XFOR

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameritas Investment Partners's XFOR Position: Q2 2025 in Review

Ameritas Investment Partners sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 339 shares — an estimated $2.4K sold.

Ameritas Investment Partners first reported a position in XFOR in Q1 2018 and held it in 21 quarters. The position peaked at $19.7K in Q2 2023. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

Ameritas Investment Partners reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Ameritas Investment Partners sold 339 X4 Pharmaceuticals shares in Q2 2025, an estimated $2.4K.
Ameritas Investment Partners first reported a position in X4 Pharmaceuticals in Q1 2018 and held it in 21 quarters.
Ameritas Investment Partners's X4 Pharmaceuticals position peaked at $19.7K in Q2 2023.
51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.